Dilation Capital Management’s Linde LIN Stock Holding History

Dilation Capital Management’s Portfolio LIN Stock Details LIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,645	Closed	-$6.27M	–	25
2026 Q1	$6.27M	Buy	+12,645	New	+$5.97M	3.15%	17

Other funds holding LIN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dilation Capital Management's LIN Position: Q2 2026 in Review

Dilation Capital Management sold out of Linde (LIN) in Q2 2026, closing a stake of 12,645 shares — an estimated $6.27M sold.

Dilation Capital Management first reported a position in LIN in Q1 2026 and held it in 1 quarter. The position peaked at $6.27M in Q1 2026. 2,341 funds tracked by Wall St. Rank hold LIN as of Q2 2026.

Dilation Capital Management reported no remaining Linde position as of Q2 2026 after selling out during the quarter.
Dilation Capital Management sold 12,645 Linde shares in Q2 2026, an estimated $6.27M.
Dilation Capital Management first reported a position in Linde in Q1 2026 and held it in 1 quarter.
Dilation Capital Management's Linde position peaked at $6.27M in Q1 2026.
2,341 funds tracked by Wall St. Rank held Linde as of Q2 2026.

Based on Dilation Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.